The ESC Textbook of Intensive and Acute Cardiovascular Care

Emergency Physicians ◽

Life Years ◽

Cardiovascular Care ◽

Acute Cardiac Care

Cardiovascular diseases (CVDs) are a major cause of premature death worldwide and a cause of loss of disability-adjusted life years. For most types of CVD early diagnosis and intervention are independent drivers of patient outcome. Clinicians must be properly trained and centres appropriately equipped in order to deal with these critically ill cardiac patients. This new updated edition of the textbook continues to comprehensively approach all the different issues relating to intensive and acute cardiovascular care and addresses all those involved in intensive and acute cardiac care, not only cardiologists but also critical care specialists, emergency physicians and healthcare professionals. The chapters cover the various acute cardiovascular diseases that need high quality intensive treatment as well as organisational issues, cooperation among professionals, and interaction with other specialities in medicine.

Intensive and acute cardiac care: an introduction

10.1093/med/9780199687039.003.0001 ◽

2015 ◽

Author(s):

Susanna Price ◽

Marco Tubaro ◽

Pascal Vranckx ◽

Christiaan Vrints

Keyword(s):

Patient Outcome ◽

Cardiovascular Diseases ◽

Early Diagnosis ◽

Premature Death ◽

Cardiac Care ◽

Life Years ◽

Cardiovascular Care ◽

Acute Cardiac Care

Cardiovascular diseases (CVDs) are a major cause of premature death worldwide and an important cause of loss of disability-adjusted life years. For most types of CVD, early diagnosis and intervention are independent drivers of patient outcome. Clinicians must be properly trained and centers appropriately equipped in order to deal with these critically ill cardiac patients. The textbook explores the intricate nature of Intensive and Acute Cardiovascular Care and provides assistance for diagnosis and preventive care across the multitude of cardiovascular diseases.

Intensive and acute cardiovascular care: an introduction

The ESC Textbook of Intensive and Acute Cardiovascular Care ◽

10.1093/med/9780198849346.003.0001 ◽

2021 ◽

pp. 1-2

Author(s):

Eric Bonnefoy-Cudraz ◽

Susanna Price ◽

Marco Tubaro ◽

Pascal Vranckx ◽

Christiaan Vrints

Keyword(s):

Patient Outcome ◽

Cardiovascular Diseases ◽

Early Diagnosis ◽

Critically Ill ◽

Premature Death ◽

Cardiac Patients ◽

Life Years ◽

Cardiovascular Care

Cardiovascular diseases (CVDs) are a major cause of premature death worldwide and an important cause of loss of disability-adjusted life years. For most types of CVD early diagnosis (within minutes) and intervention are independent drivers of patient outcome. Clinicians must be properly trained and centres appropriately equipped in order to deal with these critically ill cardiac patients.

The ESC Textbook of Intensive and Acute Cardiovascular Care

10.1093/med/9780199687039.001.0001 ◽

2015 ◽

Cited By ~ 10

Keyword(s):

Healthcare Professionals ◽

Ethical Issues ◽

Laboratory Medicine ◽

Cardiac Care ◽

Emergency Physicians ◽

Donor Organ ◽

Organizational Issues ◽

Care Association ◽

Cardiovascular Care ◽

Acute Cardiac Care

The ESC Textbook of Intensive and Acute Cardiovascular Care is the official textbook of the Acute Cardiovascular Care Association (ACCA) of the ESC. This new updated edition continues to comprehensively approach all the different issues relating to intensive and acute cardiovascular care. It is addressed to all those involved in intensive and acute cardiac care, from cardiologists to emergency physicians and healthcare professionals. The chapters cover the various acute cardiovascular diseases that need high quality intensive treatment, but also organizational issues, cooperation among professionals, and interaction with other specialities in medicine. The largest section of the textbook is devoted to non-cardiac disease which could acutely involve the cardiovascular system. Other noteworthy chapters are on ethical issues important in acute cardiac care, such as patient safety, donor organ management and palliative care. A unique characteristic of the title is the presence of a whole section devoted to biomarkers, which underline the growing importance of laboratory medicine in the field of intensive and acute cardiac care.

Trends and Risk Factors of Mortality and Disability-Adjusted Life Years for Cardiovascular Diseases from 1990 to 2017: Systematic Analysis for the Global Burden of Disease Study 2017

SSRN Electronic Journal ◽

10.2139/ssrn.3724861 ◽

2020 ◽

Author(s):

Zhenkun Wang ◽

Zhishui Chen ◽

Congyi Wang ◽

Aihua Du ◽

Hong Liu ◽

...

Keyword(s):

Risk Factors ◽

Cardiovascular Diseases ◽

Burden Of Disease ◽

Global Burden Of Disease ◽

Global Burden ◽

Systematic Analysis ◽

Life Years ◽

Disease Study

Estimation of Burden of Cystic Echinococcosis in Iran Using Disability Adjusted Life Years (DALYs) in 2018

Iranian Journal of Public Health ◽

10.18502/ijph.v50i11.7586 ◽

2021 ◽

Author(s):

Fateme Parandin ◽

Fatemeh Heydarpour ◽

Mehdi Mohebali ◽

Ahmad Ali Hanafi-Bojd ◽

Ali Akbari Sari ◽

...

Keyword(s):

Premature Death ◽

Years Of Life Lost ◽

Public Concern ◽

Policy Makers ◽

Control Programs ◽

Life Years ◽

Standard Life ◽

And Control

Background: Human hydatidosis as a public concern has increased in a number of countries that have reduced control programs for the disease due to lack of resources or policies. We aimed to estimate Disability-Adjusted Life Years (DALYs) for human hydatidosis in Iran in 2018. Methods: Data were collected from the Center of Communicable Diseases Control, Ministry of Health &Medical Education, Tehran, Iran in 2018. To calculate DALYs, years of life lost due to premature death (YLL) with years of life with disability (YLD) were calculated according to the formula as DALY = YLL + YLD. The standard life expectancy lost method (SEYLL) was used to calculate the years lost due to premature death. Results: DALYs for human hydatidosis was calculated as 1210.12 years (YLD equals to 177.12 and YLL equals to 1033) in Iran for the year 2018. It was estimated to be 700.2 years for men and 509.8 years for women. DALYs in men were significantly different from women (P= 0.001) so DALYs were more in men than women were. YLD was calculated at 78.228 years in men and 98.892 years in women and in both men and women at 177.12 years. YLD was significantly different in women compared to men (P=0.001), so YLD in women was more than in men. Conclusion: We reached considerable indices for hydatidosis in our study. Therefore, disease prevention and control programs in Iran seem necessary by the policy makers.

The global unmet need of congenital cardiac care: a quantitative analysis of the global burden of disease

Cardiology in the Young ◽

10.1017/s1047951120002577 ◽

2020 ◽

Vol 30 (11) ◽

pp. 1688-1693 ◽

Cited By ~ 1

Author(s):

Dominique Vervoort ◽

Marcelo Cardarelli

Keyword(s):

Burden Of Disease ◽

Unmet Need ◽

Morbidity And Mortality ◽

Global Burden Of Disease ◽

Cardiac Care ◽

Global Burden ◽

Life Years ◽

The World

AbstractBackground:CHDs are one of the most frequent congenital malformations, affecting one in hundred live births. In total, 70% will require treatment in the first year of life, but over 90% of cases in low- and middle-income countries receive no treatment or suboptimal treatment. As a result, CHDs are responsible for 66% of preventable deaths due to congenital malformations in low- and middle-income countries. This study examines the unmet need of congenital cardiac care around the world based on the global burden of disease.Materials and methods:CHD morbidity and mortality data for 2006, 2011, and 2016 were collected from the Institute for Health Metrics and Evaluation Global Burden of Disease Results Tool and analysed longitudinally to assess trends in excess morbidity and mortality.Results:Between 2006 and 2016, a 20.7% reduction in excess disability-adjusted life years and 20.6% reduction in excess deaths due to CHDs were observed for children under 15. In 2016, excess global morbidity and mortality due to CHDs remained high with 14,788,418.7 disability-adjusted life years and 171,761.8 paediatric deaths, respectively. In total, 90.2% of disability-adjusted life years and 91.2% of deaths were considered excess.Conclusion:This study illustrates the unmet need of congenital cardiac care around the world. Progress has been made to reduce morbidity and mortality due to CHDs but remains high and largely treatable around the world. Limited academic attention for global paediatric cardiac care magnifies the lack of progress in this area.

Using Disability-Adjusted Life Years to assess the burden of road traffic injuries in Nay Pyi Taw, Myanmar

10.1101/2020.04.26.20080325 ◽

2020 ◽

Author(s):

Win Ei Ei Thaw ◽

Wantanee Phanprasit ◽

Kwanjai Amnatsatsue ◽

Ariya Bunnagamchairat ◽

Kanitta Bundhamcharoen

Keyword(s):

Traffic Accidents ◽

Road Traffic ◽

Public Health Problem ◽

Premature Death ◽

Local Data ◽

Cross Sectional ◽

Traffic Injury ◽

Life Years

ABSTRACTBackgroundRoad traffic injury (RTI) is growing public health problem in Myanmar. In addition, every count in road crush is followed by remarkable burdens in the community. In this study, burden of disease (BOD) approach is used to quantify this hidden problem in the studied area.Aim/Objective/PurposeTo assess the burden of traffic injuries in Nay Pyi Taw Union Territory, MyanmarMethodsThis cross-sectional study analyzed 16,338 traffic injury victims in injury registry, from 2012 to 2016. The burden was estimated by disability-adjusted life years (DALYs). The analysis was disaggregated by sex, age and type of road users, as well as expressed the rate by per 100,000 population.Results/OutcomesIt was 60,962 DALYs in total for the studied period, with the rate of 1050.85 per 100,000 population. Although premature death in road crash was only 6.2% in the study, it attributed 87.8% of total burden. Total DALYs contributed by male were three-times higher than female. Nearly half of burden came from the young and productive population of 15-29 years. The highest DALYs rate was seen in the 20-24 years in male and 30-34 years in female. The highest RTI burden was due to motorized two-wheelers, with 69.4% of total DALYs.ConclusionThis study initiates usefulness of local data from injury registry to calculate the burden of injury. The findings highlight a huge burden of traffic injuries in the community, focusing on the hidden contribution of fatal cases and the vulnerability of young adult, male and motorcyclists in traffic accidents.

Global burden of diabetes and depression

10.1093/med/9780198789284.003.0001 ◽

2018 ◽

Author(s):

Julio Licinio ◽

Andreas L. Birkenfeld ◽

Stefan R. Bornstein

Keyword(s):

Premature Death ◽

First Century ◽

Average Life ◽

Average Life Expectancy ◽

Ongoing Research ◽

Life Years ◽

Years Lived With Disability ◽

Specific Country

Diabetes and depression are two of the major global health concerns in the twenty-first century. One way of measuring the global impact of these illnesses are the disability-adjusted life-years or DALYs. The calculation takes into account the average life expectancy of a specific country, the years lost by premature death, and the years lived with disability/disease. Furthermore, ongoing research has shown that interactions exist between depression and diabetes. Diabetes and other chronic diseases can lead to depression, while depression can increase the risk for developing diabetes or worsen the course of diabetes. In this book, the current understanding of the interactions between depression and diabetes will be discussed, highlighting various pathways in which these morbidities are linked. In addition, the authors give outlooks on how diabetes and depression might be treated in the future.

Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017

European Journal of Preventive Cardiology ◽

10.1177/2047487320949414 ◽

2020 ◽

pp. 204748732094941

Author(s):

Paolo A Cortesi ◽

Carla Fornari ◽

Fabiana Madotto ◽

Sara Conti ◽

Mohsen Naghavi ◽

...

Keyword(s):

Risk Factors ◽

Cardiovascular Disease ◽

Cardiovascular Diseases ◽

Disease Burden ◽

European Countries ◽

Vascular Risk ◽

Life Years ◽

Disease Study

Aims An exhaustive and updated estimation of cardiovascular disease burden and vascular risk factors is still lacking in European countries. This study aims to fill this gap assessing the global Italian cardiovascular disease burden and its changes from 1990 to 2017 and comparing the Italian situation with European countries. Methods All accessible data sources from the 2017 Global Burden of Disease study were used to estimate the cardiovascular disease prevalence, mortality and disability-adjusted life years and cardiovascular disease attributable risk factors burden in Italy from 1990 to 2017. Furthermore, we compared the cardiovascular disease burden within the 28 European Union countries. Results Since 1990, we observed a significant decrease of cardiovascular disease burden, particularly in the age-standardised prevalence (–12.7%), mortality rate (–53.8%), and disability-adjusted life years rate (–55.5%). Similar improvements were observed in the majority of European countries. However, we found an increase in all-ages prevalence of cardiovascular diseases from 5.75 m to 7.49 m Italian residents. Cardiovascular diseases still remain the first cause of death (34.8% of total mortality). More than 80% of the cardiovascular disease burden could be attributed to known modifiable risk factors such as high systolic blood pressure, dietary risks, high low density lipoprotein cholesterol, and impaired kidney function. Conclusions Our study shows a decline in cardiovascular mortality and disability-adjusted life years, which reflects the success in reducing disability, premature death and early incidence of cardiovascular diseases. However, the burden of cardiovascular diseases is still high. An approach that includes the cooperation and coordination of all stakeholders of the Italian National Health System is required to further reduce this burden.

The burden of atherosclerosis in Portugal

European Heart Journal - Quality of Care and Clinical Outcomes ◽

10.1093/ehjqcco/qcaa060 ◽

2020 ◽

Author(s):

João Costa ◽

Joana Alarcão ◽

Francisco Araujo ◽

Raquel Ascenção ◽

Daniel Caldeira ◽

...

Keyword(s):

Burden Of Disease ◽

Clinical Manifestations ◽

Premature Death ◽

Mortality Data ◽

Years Of Life Lost ◽

Mainland Portugal ◽

Life Years ◽

Years Lived With Disability

Abstract Aims This article sought to estimate the burden of disease attributable to atherosclerosis in mainland Portugal in 2016. Methods and results The burden of atherosclerosis was measured in disability-adjusted life years following the latest 2010 Global Burden of Disease (GBD) methodology. Disability-adjusted life years were estimated as the sum of years of life lost (YLL) with years lived with disability (YLD). The following clinical manifestations of atherosclerosis were included: ischaemic heart disease (IHD) (including acute myocardial infarction, stable angina, and ischaemic heart failure), ischaemic cerebrovascular disease (ICVD), and peripheral arterial disease (PAD). Years of life lost were estimated based on all-cause mortality data for the Portuguese population and mortality due to IHD, ICVD, and PAD for the year 2016 sourced from national statistics. Standard life expectancy was sourced from the GBD study. Years lived with disability corresponded to the product of the number of prevalent cases by an average disability weight for all possible combinations of disease. Prevalence data for the different clinical manifestations of atherosclerosis were sourced from epidemiological studies. Disability weights were sourced from the published literature. In 2016, 15 123 deaths were attributable to atherosclerosis, which corresponded to 14.3% of overall mortality in mainland Portugal. Disability-adjusted life years totalled 260 943, 75% due to premature death (196 438 YLL) and 25% due to disability (64 505 YLD). Conclusion Atherosclerosis entails a high disease burden to society. A large part of this burden would be avoidable if evidence-based effective and cost-effective interventions targeting known risk factors, from prevention to treatment, were implemented.